The Latest Analyst Ratings for Agilon Health
Portfolio Pulse from Benzinga Insights
Agilon Health (NYSE:AGL) received 5 analyst ratings in the last quarter, with 3 bullish and 2 somewhat bullish. No indifferent, somewhat bearish, or bearish ratings were given. The average 12-month price target for AGL is $22.4, with a high of $28.00 and a low of $16.00, representing a 13.01% decrease from the previous target of $25.75.
November 13, 2023 | 5:00 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Agilon Health has received positive ratings from analysts, with an average price target of $22.4, which is lower than the previous target by 13.01%.
The positive analyst ratings suggest confidence in the company's prospects, which could be a good sign for investors. However, the decrease in the average price target may indicate some caution about the company's future performance. The impact on the stock price is likely to be neutral in the short term as the positive ratings are balanced by the lowered price target.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100